Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial

医学 因子IX 不利影响 血友病 内科学 血友病B 血液学 入射(几何) 胃肠病学 外科 血友病A 光学 物理
作者
Feng Xue,Huiyuan Li,Xia Wu,Wei Liu,Feixu Zhang,Dingyue Tang,Yunfei Chen,Wentian Wang,Ying Chi,Zheng Jing,Zengmin Du,Wei Jiang,Chen Zhong,Jun Wei,Ping Zhu,Rongfeng Fu,Xiao Fan Liu,Ling‐Ling Chen,Xiaolei Pei,Junjiang Sun
出处
期刊:The Lancet Haematology [Elsevier BV]
卷期号:9 (7): e504-e513 被引量:49
标识
DOI:10.1016/s2352-3026(22)00113-2
摘要

A novel, engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX (FIX) protein (BBM-H901) has been developed and is promising for haemophilia B gene therapy. We aimed to explore its safety and activity in increasing FIX concentrations and reducing bleeding frequency.We did a single-centre, single-arm, phase 1, pilot trial evaluating the safety and activity of a single intravenous infusion of BBM-H901 at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (Tianjin, China). We enrolled adult patients with haemophilia B (aged >18 years) with baseline FIX coagulation activity (FIX:C) of less than 2 IU/dL, no FIX inhibitor, and low titre of neutralising antibodies (≤1:4) against vector capsid. Eligible participants were intravenously infused with a single dose of 5 × 1012 vector genomes (vg)/kg of BBM-H901 after 1 week of prophylactic prednisone treatment (1 mg/kg per day). Primary endpoints were the incidence of treatment-related adverse events, change in alanine aminotransferase (ALT) and aspartate amino transferase (AST), and development of antibodies against vector capsid within 1 year of infusion. We report the results of the prespecified 1-year analysis following complete enrolment. The trial is registered with ClinicalTrials.gov, NCT04135300, and is complete.Between Oct 16, 2019, and Jan 13, 2021, 12 male participants were assessed, and ten Chinese participants were enrolled and infused with BBM-H901. After a median follow-up of 58 weeks (IQR 51·5-99·5), mean FIX:C reached mean 36·9 IU/dL (SD 20·5). No serious adverse events, no grade 3-4 adverse events were observed. Grade 1-2 adverse events related to BBM-H901 include pyrexia (1 [10%]) and elevation of aminotransferase(1 [10%]). No FIX inhibitors were observed. All participants developed antibodies against vector capsid after infusion. Eight (80%) participants had ALT and AST concentrations below the upper limit of normal throughout the follow-up period. Two (20%) participants had elevation of ALT and AST accompanied with decrease of FIX:C, which remained at 7 IU/dL and 11.8 IU/dL, respectively.This pilot study suggests that liver-tropic BBM-H901 is safe 1 year after infusion. Vector derived FIX:C concentration is sufficiently high to prevent bleeding events and minimise the need for replacement therapy in small populations with haemophilia B. These findings support further study.Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences, National Key Research and Development Program of China, National Natural Science Foundation of China, Tianjin Municipal Science and Technology Commission Grant, and Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
彩色开山完成签到,获得积分10
1秒前
热心的秋莲完成签到,获得积分10
1秒前
寒梅恋雪发布了新的文献求助10
2秒前
ding应助外向的醉易采纳,获得10
2秒前
可问春风完成签到,获得积分10
3秒前
体贴凌柏完成签到,获得积分10
4秒前
贫穷的塔姆完成签到,获得积分10
5秒前
我在南湾湖边完成签到,获得积分10
5秒前
快乐的雨竹完成签到,获得积分10
6秒前
虚心的雁完成签到,获得积分10
7秒前
浩浩完成签到 ,获得积分0
8秒前
9秒前
lpx43完成签到,获得积分10
9秒前
zz2905发布了新的文献求助10
12秒前
一蓑烟雨完成签到,获得积分10
12秒前
12秒前
14秒前
崔崔发布了新的文献求助10
15秒前
ff不吃芹菜完成签到,获得积分10
16秒前
叶子完成签到,获得积分10
16秒前
唐唐完成签到,获得积分10
17秒前
123发布了新的文献求助10
17秒前
20秒前
朵朵完成签到,获得积分10
22秒前
发呆的小号完成签到 ,获得积分10
22秒前
充电宝应助原本采纳,获得10
24秒前
山260完成签到 ,获得积分10
24秒前
badada完成签到,获得积分10
24秒前
田様应助科研通管家采纳,获得10
26秒前
大模型应助科研通管家采纳,获得10
26秒前
科研通AI2S应助科研通管家采纳,获得10
26秒前
伶俐乐菱应助科研通管家采纳,获得10
27秒前
27秒前
27秒前
27秒前
shadow完成签到,获得积分10
28秒前
sen123完成签到,获得积分10
29秒前
123完成签到,获得积分20
30秒前
31秒前
NATURECATCHER完成签到,获得积分10
31秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038235
求助须知:如何正确求助?哪些是违规求助? 3575992
关于积分的说明 11374009
捐赠科研通 3305760
什么是DOI,文献DOI怎么找? 1819276
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022